Skip to main content
Premium Trial:

Request an Annual Quote

MDRNA Issued Chinese Patent on Use of Nucleic Acids to Treat Cancer

Premium

MDRNA said this week that it has been issued a Chinese patent covering the use of nucleic acids, including siRNAs, in treating cancer.

Specifically, the company said that the patent describes the modulation of claudins, which are proteins associated with tumor progression and metastasis.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.